View Older Stories

Feb 23, 2026 06:06AM Merck (MRK) to split human-health business into two divisions - WSJ

Feb 20, 2026 06:00AM Barclays Starts Merck (MRK) at Overweight

Feb 19, 2026 05:27AM Merck reports positive second-season data for RSV drug in high-risk children

Feb 18, 2026 06:45AM Merck and Mayo Clinic partner on AI drug discovery collaboration

Feb 13, 2026 07:46AM Merck stock upside: Why Deutsche Bank sees 26% growth despite Keytruda patent

Feb 13, 2026 07:20AM Deutsche Bank Upgrades Merck (MRK) to Buy

Feb 12, 2026 06:45AM Merck presents cancer treatment data at ASCO GU symposium

Feb 11, 2026 06:45AM FDA approves Merck's KEYTRUDA and KEYTRUDA QLEX for ovarian cancer

Feb 10, 2026 04:52PM FDA approves Merck's (MRK) Keytruda for platinum-resistant ovarian cancer patients

Feb 10, 2026 03:56PM Merck (MRK): FDA approves pembrolizumab with paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, primary peritoneal carcinoma

Feb 6, 2026 07:33AM Merck (MRK) PT Raised to $140 at Guggenheim, 'continue to see MRK as one of our Top Picks'

Feb 4, 2026 07:54AM Merck (MRK) PT Raised to $100 at Bernstein SocGen Group

Feb 4, 2026 05:56AM Merck (MRK) PT Raised to $135 at Wells Fargo

Feb 4, 2026 05:48AM Merck (MRK) PT Raised to $109 at Morgan Stanley

Feb 4, 2026 05:48AM Merck (MRK) PT Raised to $132 at BofA Securities

Feb 4, 2026 05:43AM Merck (MRK) PT Raised to $135 at BMO Capital

Feb 3, 2026 06:48AM Merck shares fall as 2026 guidance disappoints despite solid Q4 results

Feb 3, 2026 06:31AM Merck (MRK) Reports In-Line Q4 EPS; offers guidance

Feb 2, 2026 10:00PM Merck preview: focus on post-Keytruda growth path

Feb 2, 2026 10:26AM Merck (MRK) call put ratio 2.1 calls to 1 put into quarter results

Feb 2, 2026 05:07AM Merck (MRK) call put ratio 1.7 calls to 1 put into quarter results

Jan 30, 2026 11:22AM Merck (MRK) call put ratio 1 call to 1.9 puts into quarter results

Jan 30, 2026 05:52AM Merck (MRK) call put ratio 1.7 calls to 1 put into quarter results

Jan 28, 2026 02:27PM Merck Is Said To Seek $30M Stake In Eikon Therapeutics IPO - Bloomberg

Jan 27, 2026 03:07PM Merck (MRK) Declares $0.85 Quarterly Dividend; 3.2% Yield

Jan 26, 2026 08:59AM Truist Securities keeps Revolution (RVMD) at Buy, 'believe that RVMD is well funded and doesn't need to do a deal'

Jan 26, 2026 08:43AM Revolution Medicines stock falls after Merck reportedly ends acquisition pursuit

Jan 25, 2026 02:35PM Merck ends acquisition talks with Revolution Medicines - WSJ

Jan 21, 2026 10:00AM This U.S. biotech stock is Bernstein's Top Pick for 2026

Jan 21, 2026 05:22AM Merck (MRK) Added to BofA US 1 List, Apple (AAPL) Remains On

Jan 20, 2026 09:32AM Bernstein Reiterates Market Perform Rating on Merck (MRK)

Jan 20, 2026 06:28AM Merck (MRK) PT Raised to $120 at TD Cowen

Jan 20, 2026 06:21AM Merck (MRK) PT Raised to $124 at Leerink Partners

Jan 20, 2026 06:01AM Moderna and Merck report sustained melanoma treatment benefits at 5 years

Jan 20, 2026 06:00AM Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in P

Jan 15, 2026 06:02AM FDA delays reviews of Sanofi's Tzield and Disc Medicine's bitopertin

Jan 12, 2026 09:56AM Merck (MRK) Reiterated at Buy by UBS: Bags FDA CNPV Voucher for Sac-TMT

Jan 11, 2026 04:00AM Wells lists 14 high-conviction long ideas for Q1 2026

Jan 9, 2026 03:55PM STAT reported Feuerstein: meeting with Revolution Medicines CEO cancelled

Jan 9, 2026 03:02PM Merck in Talks to Buy Revolution Medicines for Around $30 Billion -- WSJ

Jan 9, 2026 02:44PM Revolution Medicines (RVMD) CEO Said to Cancel Upcoming Meetings Amid M&A Chatter

Jan 8, 2026 04:46PM After-hours movers: Rocket Companies, General Motors, Intel, and more

Jan 8, 2026 04:34PM Merck Discussed $28B-$32B Price For Revolution Medicines - FT

Jan 8, 2026 03:44PM Merck (MRK) in Talks to buy Revolution Medicines (RVMD) - FT

Jan 8, 2026 11:16AM Merck (MRK) call put ratio 3.1 calls to 1 put into the annual J.P. Morgan Healthcare Conference

Jan 8, 2026 08:39AM Merck upgraded on post-Keytruda growth, AbbVie cut as upside baked in - Wolfe

Jan 8, 2026 06:42AM Wolfe Research Upgrades Merck (MRK) to Outperform

Jan 5, 2026 06:04AM Allegro MicroSystems, Inc. (ALGM) Wells Fargo 14 High-Conviction 2026 Ideas

Jan 2, 2026 10:52AM BofA unveils its top 10 U.S. ideas for Q1 2026

Jan 2, 2026 08:43AM BofA: 'our Top 10 Ideas include nine Buys and one Underperform across nine industries'

View Older Stories